Research programme: siRNA based cardiac disease therapeutics - PRAMOMOLECULAR
Latest Information Update: 17 Nov 2023
At a glance
- Originator PRAMOMOLECULAR
- Class Drug conjugates; Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Heart failure